MENINGITIS Vaccine To Be FREELY Distributed In Africa?
March 30-2007:
Definition of Meningitis:
Infectious disease characterized by inflammation of the meninges (the tissues that surround the brain or spinal cord), usually caused by a bacterial infection. Symptoms include headache, and stiff neck, fever and nausea:
Today the BBC news reported that the above vaccine will be given to Africa for FREE, to help prevent the deadly disease of Meningitis.
The pharmaceutical corporation that produces this vaccine does not want any profit from this venture in Africa. And this vaccine will be sold very cheaply locally,a in Africa.
Today the BBC news reported that the above vaccine will be given to Africa for FREE, to help prevent the deadly disease of Meningitis.
The pharmaceutical corporation that produces this vaccine does not want any profit from this venture in Africa. And this vaccine will be sold very cheaply locally,a in Africa.
So the questions to follow this now is, WHY AFRICA?
* Why is Africa and Africans to be the first to use this untried vaccine?
* And what about the adverse or side effects (if any), from this vaccine?
* And was there a trial before this vaccine was determined to be safe?
* And if there was a trial or trials, who were the volunteers?
* Were they African men and women, or Europeans?
* And should there be future complications from recipients of this vaccine, would they be compensated by the pharmaceutical corporation providing it?
* Or from the African state that allows its' distribution and application?
These questions need to be addressed, and made internationally known!
These questions need to be addressed, and made internationally known!
Derryck S. Griffith.
Educator-Advocate & Blogger.
Educator-Advocate & Blogger.
1 Comments:
ATTENTION:
The correct name for this drug is
GLOBORIX.
Sincerely,
Derryck.
Post a Comment
<< Home